Literature DB >> 6447906

Dynamics of regression of right ventricular hypertrophy in rats with hypoxic pulmonary hypertension.

D Kentera, D Susić.   

Abstract

Normobaric hypoxia caused a significant increase in right/left ventricular weight ratio in rats, a reliable indicator of hypertrophy of the right ventricle, already after 1 week of intermittent hypoxic confinement 7 days after termination of a 4-week hypoxic exposure the right/left ventricular weight ratio was significantly lower compared to the values immediately after hypoxic treatment. 8 weeks of sojourning in a normoxic environment were not sufficient to normalize the right ventricular systolic pressure and right/left ventricular weight ratio. It is concluded that changes in the right ventricular mass in rat is a fast reaction to the changes in pressure load.

Entities:  

Mesh:

Year:  1980        PMID: 6447906     DOI: 10.1159/000194227

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  5 in total

1.  Ouabain arrhythmogenicity in hypertrophied right and left ventricle of the rat.

Authors:  D Kentera; D Susić; V Veljković; M Zdravković
Journal:  Basic Res Cardiol       Date:  1987 May-Jun       Impact factor: 17.165

2.  Separate and combined use of verapamil, aspirin and captopril in experimental chronic pulmonary hypertension.

Authors:  D Kentera; D Susić; M Zdravković
Journal:  Basic Res Cardiol       Date:  1984 May-Jun       Impact factor: 17.165

3.  Effects of SQ 14.225, an orally active inhibitor of angiotensin-converting enzyme, on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.

Authors:  D Kentera; D Susić; A Cvetković; G Djordjević
Journal:  Basic Res Cardiol       Date:  1981 May-Jun       Impact factor: 17.165

4.  Isometric relaxation of hypertrophied right ventricle in rats.

Authors:  D Kentera; D Susić
Journal:  Basic Res Cardiol       Date:  1986 Jan-Feb       Impact factor: 17.165

Review 5.  Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

Authors:  Hossein A Ghofrani; Ian H Osterloh; Friedrich Grimminger
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.